MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...
From rural clinics to cutting-edge labs, AI and biosensing technologies are revolutionizing how sickle cell disease is detected and monitored. These tools promise faster, more accurate, and more ...